Form 8-K - Current report:
SEC Accession No. 0001193125-24-178937
Filing Date
2024-07-15
Accepted
2024-07-15 11:54:00
Documents
18
Period of Report
2024-07-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d829862d8k.htm   iXBRL 8-K 26436
2 EX-99.1 d829862dex991.htm EX-99.1 24310
7 GRAPHIC g829862g0715103449331.jpg GRAPHIC 2288
8 GRAPHIC g829862g0715103449722.jpg GRAPHIC 6967
9 GRAPHIC g829862g0715103450012.jpg GRAPHIC 10441
  Complete submission text file 0001193125-24-178937.txt   235601

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20240715.xsd EX-101.SCH 3222
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plrx-20240715_def.xml EX-101.DEF 12923
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20240715_lab.xml EX-101.LAB 21033
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20240715_pre.xml EX-101.PRE 13619
20 EXTRACTED XBRL INSTANCE DOCUMENT d829862d8k_htm.xml XML 5040
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 241116414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)